CNTN earnings: real EPS beat/miss history, analyst consensus Hold, P/E -5.81. Updated 2026-07-23.
Canton Strategic Holdings (CNTN) Research Hub
Canton Strategic Holdings (CNTN) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 2.11 USD (-4.52%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -5.81, market cap 0.07B. This hub links to the full technical, earnings and options research available for CNTN.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.11 USD (-4.52%) |
| 52-week range | 1.75 USD – 3.64 USD |
| Trend regime | Range |
| 14-day RSI | 64.6 (Bullish) |
| Trailing P/E | -5.81 |
| Market cap | 0.07B |
| Dividend yield | 0.00% |
Available research for CNTN
Covered Call on CNTN: how it works, illustrative setup around the real 2.11 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CNTN: how it works, illustrative setup around the real 2.11 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CNTN: how it works, illustrative setup around the real 2.11 USD price, max profit/loss, breakeven and when to use it. Educational.
CNTN technical analysis: range, last 2.11 USD, RSI 64.6, 52w range 1.75 USD–3.64 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is CNTN in?
Canton Strategic Holdings (CNTN) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is CNTN in an uptrend or downtrend?
As of 2026-09-11, CNTN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CNTN's trailing P/E ratio?
CNTN's trailing P/E is -5.81, with a market cap of 0.07B. See the earnings research page for full valuation detail.